Search

everythinglearnresearchcommunity

for

Search:↓

New pyrazole-based inhibitors show promise for treating metabolic diseases and other conditions.

Proteasome inhibitors are promising treatments for various cancers, autoimmune diseases, and other conditions.

New cancer treatments show promise in reducing tumor growth and improving skin regeneration in mice.

CDK inhibitors may help treat ARDS and psoriasis but need more testing for safety and effectiveness.

Triptolide effectively and safely reduces actinic keratosis lesions in mice.

PEVIII is a promising treatment for Pseudomonas aeruginosa keratitis.

Some drugs for inflammation may cause psoriasis-like hair loss.

PROTACs offer a new, precise way to treat cancer by breaking down harmful proteins.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

Compounds from Pterocarpus indicus may help treat benign prostatic hyperplasia by stopping cell growth.

Promising cancer treatments were found, but the manufacturer closed.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

New treatments may restore cancer-blocking proteins, slow prostate cancer, identify drug targets, and potentially regrow hair.

Prostaglandin E2 helps prevent hair loss from radiotherapy by protecting hair growth cells and aiding self-repair.

Activated ras can protect kidney cells from a certain substance that causes cell death.

Letrozole may help prevent seizures by reducing certain hormone levels.

PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.

Immune checkpoint inhibitors can cause scalp inflammation and hair follicle issues.

Brepocitinib improves cicatricial alopecia and reduces key immune markers.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

Compound 7p shows strong potential as an anticancer agent.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

Certain peptides can prevent hair loss in young rats caused by a cancer drug.

TAK-279 effectively reduces psoriasis symptoms and is safe.

PRMT5 inhibitors effectively fight adenoid cystic carcinoma in salivary glands.

Pazopanib treatment caused rapid hair color loss, possibly indicating its effectiveness.

PROTACs offer new ways to treat hard-to-target diseases, with promising drugs for cancer in advanced trials.

PROTACs show promise in cancer treatment by effectively degrading specific harmful proteins.